These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3376114)

  • 1. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of mitochondrial inhibitors with methylmercury on spontaneous quantal release of acetylcholine.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):315-24. PubMed ID: 2435022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes.
    Levesque PC; Hare MF; Atchison WD
    Toxicol Appl Pharmacol; 1992 Jul; 115(1):11-20. PubMed ID: 1378659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction.
    Atchison WD
    J Pharmacol Exp Ther; 1986 May; 237(2):672-80. PubMed ID: 3084765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of activation of sodium and calcium entry on spontaneous release of acetylcholine induced by methylmercury.
    Atchison WD
    J Pharmacol Exp Ther; 1987 Apr; 241(1):131-9. PubMed ID: 2437285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by Anemonia sulcata toxin II of spontaneous quantal transmitter release from mammalian motor nerve terminals.
    Molgo J; Lemeignan M; Tazieff-Depierre F
    Toxicon; 1986; 24(5):441-50. PubMed ID: 2872736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals.
    Flink MT; Atchison WD
    J Pharmacol Exp Ther; 2003 May; 305(2):646-52. PubMed ID: 12606686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.
    Haimann C; Torri-Tarelli F; Fesce R; Ceccarelli B
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1953-65. PubMed ID: 3932368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of methylmercury-induced block of nerve-evoked release of acetylcholine at the neuromuscular junction.
    Traxinger DL; Atchison WD
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):23-33. PubMed ID: 3629589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of divalent cations on the methylmercury-induced alterations of acetylcholine release.
    Traxinger DL; Atchison WD
    J Pharmacol Exp Ther; 1987 Feb; 240(2):451-9. PubMed ID: 3027312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in acetylcholine concentration, miniature end-plate potentials and synaptic vesicles in frog neuromuscular preparations during lanthanum treatment.
    Florey E; Kriebel ME
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 75(2):285-94. PubMed ID: 6138197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.
    Searl TJ; Silinsky EM
    Br J Pharmacol; 2005 Aug; 145(7):954-62. PubMed ID: 15880138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependent actions of the convulsant barbiturate, CHEB, on transmitter release at the rat neuromuscular junction.
    Nicholson GM; Spence I; Johnston GA
    Gen Pharmacol; 1990; 21(5):741-6. PubMed ID: 1980474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.